Prevalence of Abdominal Aortic Aneurysm in Patients Undergoing Coronary Angiography

This study has been completed.
Sponsor:
Information provided by:
Meir Medical Center
ClinicalTrials.gov Identifier:
NCT01239225
First received: November 7, 2010
Last updated: November 10, 2010
Last verified: October 2010
  Purpose

Abdominal aortic aneurysms (AAA) are localized, blood-filled dilations (balloon-like bulges) of the aorta. Approximately 90% of abdominal aortic aneurysms occur infrarenally (1). It is most commonly asymptomatic and can be detected randomly during screening. Its prevalence rate in men aged 65 years and more is 5 - 8% (3).

The risk factors for the occurrence of AAA are male gender, advanced age, history of atherosclerosis, cigarette smoking and 1st degree family history (4).

The prevalence rate is higher in patients with history of atherosclerosis of peripheral blood vessels and coronary arteries (5 - 7). As the size of an aneurysm increases, there is an increased risk of rupture, which can result in severe hemorrhage and death. The death rate due to rupture in the elderly population is 90% (3, 8). Elective surgical repair of the abdominal aortic aneurysm is associated with a death rate of 8% (9). Therefore, the importance of the screening of populations at elevated risk is obvious (5 - 7, 10 -14). Among imaging techniques, ultrasonographic screening for abdominal aortic aneurysm is technically simple, accurate and devoid of ionizing radiation. Ultrasonographic diagnosis of AAA is associated with a major reduction in the incidence of abdominal aortic aneurysm-related mortality (15 - 19). The sensitivity of ultrasonographic screening for abdominal aortic aneurysm is about 100% (19). The most common clinical indications for ultrasonographic screening for abdominal aortic aneurysm are a palpable abdominal mass, hemodynamic impairment of aortic system in lower extremities, pain in the chest, lower back or scrotum, and abdominal bruits.

Ultrasonography is used to screen for aneurysms when the outer aortic diameter is more than 3 cm (normal diameter of the aorta is around 2 cm (20). There is disagreement regarding the follow-up of patients after detection of abdominal aortic aneurysm in diameter of 2.6 cm - 2.9 cm (22). Random detection of abdominal aortic aneurysm where the aortic diameter is 2.6 cm, in men aged 65 years and more, have been associated with no risk for its future significant development (21). Ultrasonographic evaluation of abdominal aorta is a challenge for clinicians because of the need for the accurate detection of aortic diameter (20).


Condition Intervention Phase
Coronary Angiography
Device: Abdominal ultra-sound
Procedure: Abdominal ultrasound
Phase 4

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Primary Purpose: Diagnostic

Resource links provided by NLM:


Further study details as provided by Meir Medical Center:

Estimated Enrollment: 200
Study Start Date: September 2009
Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Abdominal ultrasound
Abdominal ultrasound
Device: Abdominal ultra-sound Procedure: Abdominal ultrasound

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • Subject is ≥ 18 years of age.
  • Subject understands study requirements and diagnostic procedures and agrees to sign an informed consent form prior to both study procedures:

    • Ultrasonographic screening of abdominal aorta (from diaphragm to aorta bifurcation) in horizontal and vertical position for the detection of aneurysms. Ultrasonographic screening will be perform in frontal technique for sagital view and in right lateral decubitus for coronal view. The outer aortic diameter will be measured in three levels: at the level of the diaphragm, at SMA level and proximal to the aorta bifurcation.
    • Coronary angiography.
  • The patients will be divided into two groups according to the results of their angiograms:

    • Normal coronary angiography (n=100).
    • Atherosclerosis of coronary arteries (n=100).
    • Subject will be available for ultrasonographic follow-up after the procedure.

Exclusion Criteria:

  • Pregnancy.
  • Subject has systemic infection, or is suspected of having systemic infection.
  • Subject has an untreatable bleeding.
  • Enrollment in another study protocol.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: Dr. Kyryl Derkach, Meir Medical Center
ClinicalTrials.gov Identifier: NCT01239225     History of Changes
Other Study ID Numbers: mmc2010137-09ctil
Study First Received: November 7, 2010
Last Updated: November 10, 2010
Health Authority: Israel: Clalit Health Services

Keywords provided by Meir Medical Center:
Patients undergoing coronary angiography

Additional relevant MeSH terms:
Aortic Aneurysm, Abdominal
Aortic Aneurysm
Aneurysm
Vascular Diseases
Cardiovascular Diseases
Aortic Diseases

ClinicalTrials.gov processed this record on July 26, 2014